Long-term data on the proposed adalimumab biosimilar BCD-057 in patients with moderate to severe psoriasis: A randomized controlled trial.

Published in:

PLoS ONE, 2022, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0263214

By:

• Samtsov, Alexey V.;
• Bakulev, Andrey L.;
• Khairutdinov, Vladislav R.;
• Kokhan, Muza M.;
• Korotaeva, Tat'yana V.;
• Minullin, Iskander K.;
• Vylegzhanina, Olga A.;
• Dubenskiy, Valery V.;
• Khalilov, Bulat V.;
• Khotko, Alkes A.;
• Zykova, Olga S.;
• Chumachenko, Irina V.;
• Lukyanov, Alexander M.;
• Artemeva, Antonina V.;
• Pukhtinskaia, Polina P.

Publication type:

Article